Regeneron aims for FDA approval of extended dosing for EYLEA HD in AMD and DME, with a decision by April 2025. Pre-filled ...

A new study by Brown University researchers suggests that gold nanoparticles - microscopic bits of gold thousands of times ...

A new study by Brown University researchers suggests that gold nanoparticles—microscopic bits of gold thousands of times ...

Medically reviewed by Christine L. Larsen, MD Myopic macular degeneration (MMD), or pathological myopia, occurs when high ...

An add-on agent designed to boost drugs that treat age-related macular degeneration failed to show any benefit in two phase 3 ...

Discover the warning signs and treatment options for myopic macular degeneration, a serious eye condition affecting people ...

Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature.It is often difficult to treat, requires a ...

The ranibizumab biosimilar Ongavia exhibited significantly less improvement in visual acuity and retinal thickness compared ...

Transplantation of retinal organoid sheets offers hope to patients afflicted with retinal degenerative diseases.

In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest ...

Among the forms of monogenic macular degeneration ... early enough and people have retained a sufficient number of retinal cells, the therapy could prevent further degeneration. This makes it ...

This study shows that smoking worsens neovascular age-related macular degeneration via the Sema4D ... neovascularization and enhances anti-VEGF therapy efficacy, offering a potential therapeutic ...